openPR Logo
Press release

Autoimmune Disease Diagnostics Market : Precise Analysis on Business Overview, Product Scope And Ongoing Market Development 2015 - 2023

08-02-2018 01:39 PM CET | Health & Medicine

Press release from: Transparency Market Research 

Autoimmune Disease Diagnostics Market : Precise Analysis

The leading four players in the global autoimmune disease diagnostics market hold almost half the share in it. This makes the competitive landscape consolidated. Nevertheless, the competition is stiff among the existing few players who are pulling out all stops to come up with more advanced and effective procedures in response to the pressing demand. A recent report on the market published by Transparency Market Research finds that it holds out a lot of promise for new comers who can tap into the demand for unique, better products. However, they might still have to contend with a few challenges resulting from competitive pricing, lessening product lifecycles, and costly research and development.

Request a Brochure of the Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=5351

The report by TMR projects the market for autoimmune disease diagnostics to attain a value of US$17.06 bn by 2023 by rising at a steady 3.8% CAGR from 2015 and 2023.

Among the various kinds of autoimmune diseases, the rheumatoid arthritis is surpassing all others when it comes to growing its share in the market for autoimmune disease diagnostic. The burgeoning geriatric population and better diagnostics of rheumatoid arthritis developed at state-of-the-art laboratories has led to the impressive growth in this segment. North America, from a geographical standpoint, at present leads the market. Canada and the U.S., which have superior healthcare infrastructure and laboratories equipped with latest equipment, are mainly driving the region’s market. The high degree of awareness about various health conditions along with the increasing spends have also served to catalyze growth in the region.

Rise in Autoimmune Diseases, alongside Growing Awareness about Them, Stokes Market

At the forefront of fuelling the global market for autoimmune disease diagnostics is the increasing instances of autoimmune diseases – millions are afflicted by it every year making it extremely necessary to diagnose those accurately. Adds the analyst our report, “Worldwide, people have become more aware about the occurrence of various kinds of autoimmune diseases and this has not just egged them to go for preventive measures, but also autoimmune disease diagnostics if need be.”

Governments of various nations are increasing their spends on healthcare owing to the rise in such diseases. They are also upping their allocations on research and development of improved diagnostics, alongside private bodies, and this is another major catalyst for the market.

Competitive Pricing Strategies by Bigger Players Crimps Revenue Growth

However, a few headwinds are crimping the pace of growth of the market for autoimmune disease diagnostics. One of them is the solid competition from numerous regional players which has forced their bigger counterparts to adopt competitive pricing. This has had a negative impact on the revenue generation in the market. Another factor hampering the market is the inadequate number of skilled professionals which create operational bottlenecks in clinical laboratories.

To overcome such bottlenecks in revenue growth, keen players in the market for autoimmune disease diagnostics are seen focusing on the upcoming economies in Asia Pacific and Latin America which are still relatively under-tapped. They are also seen focusing on automating laboratories so as to do away with conventional technologies.

Enquiry for Discount on this Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=5351

This review is based on the findings of a TMR report, titled, “Autoimmune Disease Diagnostics Market (Test Type – Antinuclear Antibody Tests, Autoantibody Tests, Complete Blood Count (CBC), Comprehensive Metabolic Panel, C-reactive Protein (CRP), Erythrocyte Sedimentation Rate (ESR), and Urinalysis; Disease Type – Graves’ Disease, Hashimoto’s Thyroiditis, Multiple Sclerosis, Rheumatoid Arthritis, Systemic Lupus Erythematosus (Lupus), and Type 1 Diabetes) – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2015–2023.”

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector – such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

Contact Us

Transparency Market Research
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: https://www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Autoimmune Disease Diagnostics Market : Precise Analysis on Business Overview, Product Scope And Ongoing Market Development 2015 - 2023 here

News-ID: 1159192 • Views:

More Releases from Transparency Market Research 

Oligonucleotide Therapeutics Market Size, Status, Scope and Growth Prospects 2020-2030
Oligonucleotide Therapeutics Market Size, Status, Scope and Growth Prospects 202 …
Global Oligonucleotide Therapeutics Market: Overview Oligonucleotides refer to short chain DNA or RNA that are generally made by using automated synthesizers. In addition, purification of oligonucleotide is accomplished by anion exchange chromatography and it is followed by the techniques of freezing and desalting. In addition, synthesis of siRNA duplex oligonucleotide is done through an annealing step in which two purified strands of oligonucleotide are brought closer together in an equimolar ratio.
Seasonal Affective Disorder Therapeutics Market Size, Status, Scope and Growth Prospects 2020-2030
Seasonal Affective Disorder Therapeutics Market Size, Status, Scope and Growth P …
Global Seasonal Affective Disorder Therapeutics Market: Overview From 2020 to 2030, the global seasonal affective disorder is set to witness new profitable avenues. It is set to chart growth at a sturdy rate, compounded annually, with massive contributions coming from the North American region. On the other hand, Asia Pacific is anticipated to grow at an impressive CAGR. Transparency Market Research notes that various factors are contributing towards the projected growth. These
Esthetic Lasers and Energy Devices Market set to witness surge in demand over the forecast period of 2017 - 2025
Esthetic Lasers and Energy Devices Market set to witness surge in demand over th …
In the past few years, the cosmetic industry has found new bioactive and high potency ingredients, which offer noticeable skin benefits to consumers. Various technological advancements in the esthetic industry, increase in disposable income, surge in awareness about skin rejuvenation & appearance are the major factors driving demand for esthetic procedures in developed as well as developing markets. The trend of adoption of innovative and advanced surgical devices in the
Image Guided Surgery Devices Market Analysis and Research Report by Experts 2025
Image Guided Surgery Devices Market Analysis and Research Report by Experts 2025
The global image guided surgery devices market is directly reliant on the development of healthcare across various regional longitudes of the world. As the healthcare industry make rapid advancements across a number of its sub-domains, the market for global image guided surgery devices would see the entry of new players into the market. The competition is expected to intensify in the coming years and wreak the need for proper strategizing

All 5 Releases


More Releases for Disease

Protheragen Announces Disease Model Development Services to Enhance Rare Disease …
Protheragen announced the release of its disease model development services provided to enhance rare disease research. With an increasing focus on rare diseases and the need for tailored research models, Protheragen is dedicated to providing cutting-edge solutions to support this important area of medical research. Rare diseases, which affect a small percentage of the population, pose unique challenges for researchers due to their limited understanding and lack of available treatment options.
Biopharmaceutical Fermentation Market 2022 | Growing Morbidity of Genetic Diseas …
According to Precision Business Insights (PBI), the latest report, the biopharmaceutical fermentation market is expected to be valued at USD 10,302.1 million in 2022, growing at a 4.7% CAGR from 2022 to 2028. The growing prevalence of chronic illness, cancer, cardiac diseases, infectious diseases, antibiotic resistance, autoimmune diseases, etc., globally causes the leaning toward biopharmaceutical products, which show promising results in the research studies. Moreover, new findings by the
Global Inflammatory Bowel Disease (IBD) Market Key Players Analysis, Disease Ind …
Global Inflammatory Bowel Disease (IBD) Market, valued at USD 210.5 Billion in the year 2020 has been driven by factors such as the increasing prevalence of Ulcerative Colitis and Crohn’s Disease, advances in medical technology, government support for inflammatory bowel disease treatment research, and the ubiquity of anxiety and depression. Moreover, factors such as the irregular food habits, unhealthy lifestyle of people, increased level of pollution and increase in alcohol
Moyamoya Disease Market - A Scientometric Assessment of Disease During 2018-23
Market Highlight: Moyamoya disease (MMD) is a chronic, cerebrovascular disease characterized by progressive stenosis in the internal carotid artery and an abnormal vascular network at the base of the brain. The stroke is one of the significant symptoms of moyamoya disease, which further leads to paralysis of the face, arms, and legs, loss of speech, and temporary loss of neurologic function of body parts, visual disturbances, headaches, developmental delay, and
Refsum Disease Industry An Overview of A New Disease - 2018
"Refsum Disease" is a genetic disorder which is inherited as an autosomal recessive trait. The condition is characterized by progressive loss of vision (retinitis pigmentosa), failure of muscle coordination (ataxia), degenerative nerve disease (peripheral neuropathy), and dry, rough, scaly skin (ichthyosis). The accumulation of fatty acid (phytanic acid) in blood plasma and tissues is the main cause of refsum disease. This occurs due to malfunction of the enzyme producing gene
Chagas Disease (Infectious Disease) Pipeline Forecast Report, H1, 2017 [MRH]
Market Research Hub's Pharmaceutical and Healthcare latest pipeline guide Chagas Disease - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Chagas Disease Market (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and